Around the world, COVID-19 has made many a bad situation worse. In doing so, it also showed the world where improvements in care can make the greatest difference.
For underserved and low-income communities facing the pandemic and a corresponding rate of diabetes and pre-diabetes, that's exactly the kind of bad-to-worse scenario that is an opportunity to make a real change.
With Mike Wilson, U.S. Equities Research for Investors
Multimedia with summary
High expectations around reopening may already be substantially priced into markets, pointing to new risks around how the reopening actually plays out.
Each week, Mike Wilson offers his perspective on the forces shaping the markets and how to separate the signal from the noise. Listen to his most recent episode and check out those of his colleagues from across Morgan Stanley Research.
Every mom deserves the highest-quality prenatal care. But many underserved pregnant women don’t have access to the care they need.
The United Health Foundation has committed a $2.6 million grant to Touro University Nevada (Touro) to improve access to high-quality prenatal care for approximately 1,700 underserved and homeless women in southern Nevada.
Funding will also be applied to initiatives that reduce maternal health disparities and grow the state’s OB-GYN and family medicine physician workforce.
New Exploratory Analyses Presented From ENLIGHTEN-2 Study of LYBALVI™ in Patients With Schizophrenia
DUBLIN, April 22, 2021 /3BL Media/ -- Alkermes plc (Nasdaq: ALKS) recently announced the presentation of new research from its psychiatry portfolio at the 2021 Congress of the Schizophrenia International Research Society (SIRS), taking place virtually April 17-21, 2021.
The partnership between TechsoMed and Lenovo is enabling physicians to target cancer with never before seen precision.
To treat cancerous tumors, physicians have long relied on surgery, chemotherapy and radiation — highly invasive treatments that push patients’ bodies to their limits. Surgically removing tumors requires long hospital stays, recovery times and extensive follow-ups. In the near future, all of this might change.
We are pleased to share clinical trial data on our investigational #immunooncology therapy and are excited to be a part of the 17th EADO Congress and 2021 World Mobile Congress Interactive Virtual Meeting. https://worldmelanoma2021.com/